Search hospitals
>
Colorado
>
Pueblo
Saint Mary Corwin Medical Center
Claim this profile
Pueblo, Colorado 81004
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
343 reported clinical trials
3 medical researchers
Summary
Saint Mary Corwin Medical Center is a medical facility located in Pueblo, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Saint Mary Corwin Medical Center is involved with conducting 343 clinical trials across 449 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Area of expertise
Breast Cancer
Saint Mary Corwin Medical Center has run 64 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Saint Mary Corwin Medical Center has run 52 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Richard L. Deming
Mercy Medical Center - Des Moines
7 years of reported clinical research
Shahzad Siddique
Penrose-Saint Francis Healthcare
3 years of reported clinical research
Mehmet S. Copur
Bethesda North Hospital
13 years of reported clinical research
Clinical Trials running at Saint Mary Corwin Medical Center
Bladder Cancer
Lung Cancer
Prostate Cancer
Breast Cancer
Breast cancer
Esophageal cancer
Ovarian Cancer
Multiple Myeloma
Bladder Carcinoma
Colorectal Cancer
Gemcitabine + Docetaxel vs BCG
for Bladder Cancer
This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting
2 awards
Phase 3
14 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Mary Corwin Medical Center?
Saint Mary Corwin Medical Center is a medical facility located in Pueblo, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Saint Mary Corwin Medical Center is involved with conducting 343 clinical trials across 449 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Where is Saint Mary Corwin Medical Center located?
St. Mary-Corwin Medical Center is located at 1008 Minnequa Avenue, Pueblo, CO 81004. To reach the hospital from I-25, take exit 101A for US-50 W toward Pueblo. Continue on US-50 W, turn right onto W 29th Street, left onto N Grand Avenue, right onto W 16th Street, and continue onto Minnequa Avenue; the hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Saint Mary Corwin Medical Center, contact (844) 853-7359. Office hours are 8:30 a.m. to 11 p.m. on weekdays, and 11 a.m. to 11 p.m. on weekends. Applications for financial assistance are available in English and Spanish; for other languages or to obtain written copies, contact a financial counselor or email billing@stmarysathens.org.
What insurance does Saint Mary Corwin Medical Center accept?
Saint Mary Corwin Medical Center, a Centura Health facility, accepts a range of insurance plans including Anthem, Cigna, Rocky Mountain, and Kaiser Permanente. Additionally, Allina Health, which operates Corwin, accepts original Medicare, most Medicare Advantage and Private-Fee-For-Service plans, Medicaid, MinnesotaCare, and select health insurance exchange plans in Minnesota and Wisconsin. It is recommended to verify insurance acceptance directly with the hospital or provider.
What awards or recognition has Saint Mary Corwin Medical Center received?
Saint Mary Corwin Medical Center, located in Pueblo, Colorado, is accredited by the Commission on Cancer (CoC), signifying its commitment to providing high-quality cancer care. The hospital is also recognized for its active participation in clinical trials through Policy Lab.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.